We demonstrated that inhibition of SERPINB2 in hBMSC led to enhanced OS and AD differentiation suggesting a negative regulatory role in OS and AD differentiation, downstream of TGF-β signalling. This evidence concerns the gene SERPINB2 and Alzheimer disease.